Ultra Rapid GEnome Sequencing

Next-generation sequencing (NGS) has revolutionized the field of genomics, allowing the detection of genetic abnormalities for diagnostic or therapeutic purposes. Turnaround times for exome or genome ...

Lead sponsor: CMC Ambroise Paré•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited Cardiomyopathy

NCT06948344 · Cardiomyopathy, Whole Genome Sequencing

RECRUITING

N-Care Project: Enhancing Asian-Pacific Collaboration

NCT06821386 · Whole Genome Sequencing, Genetic Disease, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 18, 2024Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment4

Start dateOct 2024

Last updatedDec 18, 2024

Condition

Whole Genome Sequencing

Locations shown

Institut Rafaël

Levallois-Perret, Île-de-France Region

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 18, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions